Analysis of pharmaceutical interventions on avoidable costs with pharmacotherapy in a teaching hospital in Sergipe (Brazil) in the first months of Covid-19
DOI:
https://doi.org/10.30968/rbfhss.2021.124.0705Abstract
Objectives: To assess the impact of pharmaceutical interventions on avoidable costs with pharmacotherapy in a teaching hospital in the first months of Covid-19. Methods: A cross-sectional retrospective study, with a quantitative approach carried out in a teaching hospital. The evaluated data were obtained from the documentation of interventions carried out between April and October 2020 by the institution’s clinical pharmacists. To calculate the estimated initial cost and the final cost of treatment, the value of the drug and the inputs used for administration were considered multiplied by the dosage (frequency and prescribed treatment time). In order to obtain the value saved for each intervention, the final discovered cost was subtracted from the estimated initial value of the treatment. Results: 167 pharmaceutical interventions were registered with cost reduction, generating savings corresponding to $ 9.067,83. The units that most demanded pharmaceutical interventions were Intensive Care Units (ICU) general and Covid-19. Antimicrobials stood out with the largest number of interventions related to cost reduction and with the largest amount saved. As for the type of intervention related to cost reduction, the most frequent was dose reduction due to changes in renal function (49.48%). Conclusion: Pharmaceutical interventions act as a tool to promote the rational use of medicines for their clinical and economic benefits. This study allowed to demonstrate that the pharmaceutical service can collaborate to reduce unnecessary health expenses.
Downloads
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Serlf-archiving policy
This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.
